Triple Therapy for Acute Deep Thrombophlebitis
- DISCUSSION. Perler, Bruce // Vascular Surgery;Jan/Feb2000, Vol. 34 Issue 1, p23
Focuses on the management of primary axillosubclavian venous thrombosis. Medical comorbidity experienced by patients with secondary upper extremity venous thrombosis; Use of surgical thrombectomy to prevent recurrent venous thrombosis; Safety and efficacy of urokinase compared to streptokinase...
- THROMBOLYTIC TREATMENT OF VENOUS THROMBOEMBOLISM. Gurewich, Victor // Vascular Surgery;Nov/Dec1977, Vol. 11 Issue 6, p341
Describes the thrombolytic treatment for deep venous thromboembolism. Objective of thrombolytic therapy; Pharmacologic efficacy of streptokinase and urokinase; Diagnostic procedure for venous thromboembolism.
- THROMBOLYSIS AS AN ALTERNATIVE TO PULMONARY EMBOLECTOMY. Porter, John M. // Vascular Surgery;Nov/Dec1977, Vol. 11 Issue 6, p373
Discusses the potential application of thrombolysis as an alternative to pulmonary embolectomy. Incidence and acute survival statistics of pulmonary embolism; Role of heparin in the treatment of pulmonary embolism; Evaluation of streptokinase and urokinase as thrombolytic agents.
- Thrombolytic Therapy: Agents, Indication, Clinical Performance, and Side Effects. Tilsner, V.; Greul, W. // Vascular Surgery;Mar/Apr1979, Vol. 13 Issue 2, p79
Thrombolytic therapy is successful in 70% of fresh occlusions and in over 40% of chronic occlusions. Vascular surgery is often superior to thrombolytic therapy on the arterial side, but inferior on the venous side. Streptokinase acts faster and is considerably cheaper than urokinase, but it...
- The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring. Marder, Victor J. // Annals of Internal Medicine;May79, Vol. 90 Issue 5, p802
Presents information on a study which examined the aspects of treatment faced by the practitioner or specialist who must decide if a patient's illness warrants thrombolytic therapy. Properties of Streptokinase and urokinase; Patient selection; Principles of thrombolytic therapy.
- North Baden venous lysis trial (NBVL): multicentre prospective randomized phlebographically controlled trial on the effect of ultra-high versus conventional doses of streptokinase in fresh leg—pelvis venous thromboses. Heinrich, F.; Heinrich, U. // Vascular Medicine;1998, Vol. 3 Issue 2, p87
Since no previous randomized comparison has been carried out between ultra-high and conventional dosage streptokinase therapy of fresh venous thromboses, the NBVL trial was carried out as a prospective, randomized, multicentre, phlebographically monitored comparison of the results and adverse...
- Thrombophilic defects not associated with increased risk for recurrent VTE during warfarin therapy. // Hem/Onc Today;1/10/2009, Vol. 10 Issue 1, p31
The article presents findings of a study on the association between thrombophilic defects and risk for recurrent venous thromboembolism (VTE) during warfarin therapy.
- Don't halt Coumadin, taper it? H.D.B. // Cortlandt Forum;09/25/97, Vol. 10 Issue 9, p111
Reports on concern over the cessation of Coumadin (warfarin) and the recurrences of deep venous thrombosis (DVT). Prolonging prothrombin time; Effect of Coumadin lasting for days after it is stopped; Optimal duration of therapy for DVT patients.
- Cerebral Venous Thrombosis: A Guide to Diagnosis and Drug Treatment. Hsu, F.P.; Nesbit, G.M.; Kuether, T.; Barnwell, S. // CNS Drugs;2000, Vol. 14 Issue 6, p425
Cerebral venous thrombosis (CVT) is a relatively rare pathological condition. The clinical presentations can be nonspecific and quite variable, frequently resulting in delayed or missed diagnosis. The symptoms include headache, nausea, vomiting, visual disturbance, altered consciousness and...